ASCO 2019 New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

07:58 EDT 4 Jun 2019 | ecancermedicalscience

New information about adjuvant therapy to prevent recurrence of breast cancer in women 50 years of age or younger, or premenopausal, emerged today from the landmark Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx. An analysis of a...

More From BioPortfolio on "ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients"